Medicated patch comprising 5-methyl-1-phenyl-2-(1H)-pyridone
US8287900B2 · kind B2 · utility
0Cited by
4References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 26, 2008 |
| Grant date | Oct 16, 2012 |
| Priority date | — |
| Expiry date | Feb 16, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/204
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a medicated patch including 5-methyl-1-phenyl-2-(1H)-pyridone. A medicated patch comprising a percutaneously absorbable preparation layer, wherein the percutaneously absorbable preparation layer includes 5-methyl-1-phenyl-2-(1H)-pyridone or a pharmaceutically acceptable salt thereof as an active component, a dissolving agent and an aqueous base material (or a rubber-type base material), and the active component is contained in an amount of 0.1 to 30 mass % relative to the total amount of the percutaneously absorbable preparation layer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.